Smith Sean Michael

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Smith Sean Michael's trades of Neurogene Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
388.56
Quantity 39,409
Value US$4,422,718
Transaction date
Planned sale
Price
161.92
Quantity 851 -16.1%
Value US$875,393
Transaction date
Sale
Price
451.90
Quantity 48,460 +28.7%
Value US$1,306,719
Transaction date
Sale
Price
0.99
Quantity 1,655 -19.6%
Value US$1,641
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-04 2024-03-04
PrS Proposed sale
39,409
388.56
US$4,422,718 		39,409 388.56 US$4,422,718
2023-08-14 2023-08-11
PlS Planned sale
851 -16.1%
161.92
US$875,393 		851 -16.1% 161.92 US$875,393
2023-02-03 2023-02-02
S Sale
48,460 +28.7%
451.90
US$1,306,719 		48,460 +28.7% 451.90 US$1,306,719
2022-08-12 2022-08-10
S Sale
1,655 -19.6%
0.99
US$1,641 		1,655 -19.6% 0.99 US$1,641